Last edition
News about "pharmaceutical products"
Aurobindo Pharma Expands Business in Malaysia with New Subsidiary
Aurobindo Pharma has announced the incorporation of a new wholly owned subsidiary, Aurobindo Pharma (Malaysia) SDN. BHD., through its subsidiary Helix Healthcare B.V.
Pharmaceutical Products | 18/09/2025 | By Dineshwori
US Tariffs on EU Pharma Imports Threaten Drug Access and Innovation, GlobalData Warns
The US-EU trade deal has placed the pharmaceutical industry under significant fiscal strain, with consequences that extend beyond short-term financials, according to GlobalData, a leading data and analytics company.
Pharmaceutical Products | 05/08/2025 | By Dineshwori | 132
186 Drug Samples Declared Substandard in May, 49 from Himachal Pradesh: Govt
A total of 186 drug samples were found to be ‘not of standard quality’ (NSQ) in May 2025, with 49 of them manufactured in Himachal Pradesh, Minister of State for Health and Family Welfare Anupriya Patel informed the Rajya Sabha on Tuesday in a written reply.
Pharmaceutical Products | 23/07/2025 | By Dineshwori | 121
MD Logistics to Launch Dedicated Pharmaceutical Warehouse in Indiana
The warehouse undergoing renovations is the largest in MD's network at approximately 37,000 m2.
Pharmaceutical Products | 07/10/2024 | By Aishwarya | 424
Lupin Unveils Mirabegron Extended-Release Tablets in US
Mirabegron Extended-Release Tablets, 50 mg is a generic equivalent of Myrbetriq Extended-Release Tablets, 50 mg of Astellas Pharma Global Development, Inc.
Pharmaceutical Products | 06/09/2024 | By Aishwarya | 252
Lupin Secures Tentative Approval from FDA for Brimonidine Tartrate Ophthalmic Solution
Lupin has received tentative approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for Brimonidine Tartrate Ophthalmic Solution, 0.025 percent (OTC).
Pharmaceutical Products | 16/08/2024 | By Aishwarya | 514
Alembic Pharma Received FDA Approval for Fluphenazine Hydrochloride Tablets
Alembic Pharmaceuticals Ltd. has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Fluphenazine Hydrochloride Tablets USP, 1 mg, 2.5 mg, 5 mg, and 10 mg.
Pharmaceutical Products | 25/07/2024 | By Aishwarya | 356
CDSCO Issues Guidelines to Curb Circulation of Substandard Pharmaceuticals
Central Drugs Standard Control Organisation (CDSCO) has recently issued draft guidelines on good distribution practices to curb the introduction of spurious, adulterated and sub-standard pharmaceutical products in the market.
Pharmaceutical Products | 19/04/2024 | By Aishwarya | 768
Kashmir University Hosts Lecture on Pharmaceutical Marketing Career
The placement of qualified students happens to be one of the top priorities of the university.
Pharmaceutical Products | 28/08/2023 | By Manvi | 319
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy